What is the recommended acute management for a patient with a hemorrhagic cerebrovascular accident (stroke)?

Acute Management of Hemorrhagic Stroke (Intracerebral Hemorrhage)

Treat hemorrhagic stroke as a medical emergency requiring immediate blood pressure control to systolic BP <140 mmHg using labetalol as first-line, urgent reversal of any anticoagulation, admission to a neuro-ICU or stroke unit, and neurosurgical consultation for cerebellar hemorrhages or hydrocephalus.

Initial Assessment and Diagnosis

Upon presentation, immediately:

• Obtain non-contrast CT or MRI to confirm ICH diagnosis, location, and extent 1
• Assess neurological severity using NIHSS for awake/drowsy patients or GCS for obtunded patients 1
• Check INR/PTT, platelet count, and complete medication history including all anticoagulants and antiplatelets 1
• Perform CT angiography, MR angiography, or catheter angiography to exclude underlying vascular lesions (aneurysm, AVM) 1
• Monitor for signs of increased intracranial pressure 1

Blood Pressure Management

This is the most critical modifiable factor in the hyperacute period:

• Check BP every 15 minutes until stabilized, then every 30-60 minutes for first 24-48 hours 1
• Target systolic BP <140 mmHg - there is evidence supporting safety for this target 1
• Use labetalol as first-line agent if no contraindications 1
• Aggressive dosing or IV infusion may be required to achieve targets 1

Critical caveat: While lower BP targets are safe, evidence does not show improved outcomes below 140 mmHg systolic, but does show increased renal complications with more aggressive reduction 2.

Reversal of Anticoagulation/Antiplatelet Therapy

Act immediately upon ICH diagnosis:

For Warfarin:

• Administer prothrombin complex concentrate (PCC) PLUS vitamin K 1
• PCC is preferred over fresh frozen plasma due to faster onset of action 1
• FFP and vitamin K are acceptable alternatives if PCC unavailable 1

For Antiplatelet Agents:

• Stop ASA, clopidogrel, and dipyridamole/ASA immediately 1
• Do NOT give platelet transfusion - this likely increases death/dependence (RR 1.29) 3

For DOACs:

• Urgent hematology consultation for reversal agent availability and use 1

For Factor VIIa:

• Do NOT use recombinant Factor VIIa - it prevents hematoma growth but increases arterial thromboembolic events without improving survival or outcomes 1

Neurosurgical Consultation

Obtain urgent neurosurgical consultation for:

• Cerebellar hemorrhage, particularly with altered consciousness or brainstem symptoms 1
• Acute hydrocephalus requiring external ventricular drain (EVD) 1
• Consideration of decompressive craniectomy 1

Important limitation: Surgical intervention has NOT been shown superior to conservative management for most supratentorial ICH 1. Consider surgery only in select patients with higher consciousness levels (GCS 9-12) 1.

Admission and Monitoring

• Admit to stroke unit or neuro-ICU 1
• Conduct validated neurological scale (CNS score) hourly for first 24 hours 1
• Interprofessional stroke team assessment for rehabilitation needs 1

Medications to Avoid

• No prophylactic anticonvulsants - only treat if seizures occur 1
• No statins for ICH prevention - individualize only if clear indication for cholesterol lowering, considering thrombotic risk versus ICH risk 1
• Avoid antithrombotic medications in acute period 1

Goals of Care Discussion

• Establish goals with patient/substitute decision-maker 1
• Defer DNR or palliative care decisions for 24-48 hours to allow response to medical therapy 1
• Exceptions: pre-existing wishes due to comorbidities (dementia) or previously expressed values 1
• DNR patients should still receive all other appropriate medical/surgical interventions unless explicitly indicated otherwise 1

Timing to Restart Anticoagulation

If strong indication exists (atrial fibrillation, mechanical valve):

• Decision must be case-by-case 1
• Evidence is unclear on optimal timing 1
• Consult stroke expert, cardiologist, or hematologist/thrombosis expert 1

Key Pitfall to Avoid

The 30-40% of patients who experience hematoma expansion within first hours are at highest risk for poor outcomes 1. This makes the first 24 hours absolutely critical for aggressive BP management and coagulopathy reversal - delays directly worsen mortality and morbidity.